The ALSFRS-R scale

The ALSFRS-R scale (Revised ALS Functional Rating Scale) is a concrete demonstration of your stage of the disease. It is an important resource to better gauge where you are and what your options are.

Measure Your Score Here

FDA Approved Drugs: Radicava and Riluzole



What is Radicava?

Radicava (AKA Edaravone) is a free radical scavenger which has been shown to decrease progression in ALS patients. It was approved in May of 2017 and it was the first FDA approved ALS treatment drug in the past 23 years since Riluzole. 



What is Riluzole?

Riluzole (AKA Rilutek) is a glutamate blocker which aids in expelling glutamate excitotoxicity in the body. FDA approved in 1995, the drug may increase survival by approximately two to three months.